drugset / Trial / NCT00418002

Safety and Tolerability of AQW051 in Elderly Healthy Volunteers.

NCT00418002 ↗

Phase 1 Completed 72 enrolled Novartis
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to assess safety and tolerability of AQW051 administered in single and multiple doses to elderly healthy volunteers. In addition, pharmacokinetic effects will be assessed and the possible effects on cognition.

Timeline

Start
2006-05
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject AQW051 Small molecule — Oral

Indications

No indication recorded.